Small Business Innovation Research and Small Business Technology Transfer Programs Phase I
ID: 355247Type: Posted
Overview

Buyer

National Institute of Food and Agriculture (USDA-NIFA)

Award Range

$125K - $182K

Eligible Applicants

Others

Funding Category

Agriculture

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355247

Additional Information

https://www.nifa.usda.gov/grants/funding-opportunities/small-business-innovation-research-small-business-technology-transfer
Timeline
    Description

    The National Institute of Food and Agriculture (NIFA) is inviting applications for its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs Phase I for Fiscal Year 2025. This funding opportunity aims to support small businesses in developing innovative technologies with commercial potential across various topics, including forestry, aquaculture, food science, and rural development, while also promoting diversity, equity, inclusion, and accessibility in research participation. The total anticipated funding for this initiative is $15.5 million, with individual awards ranging from $125,000 to $181,500, and applications are due by September 17, 2024. Interested applicants can reach out to NIFA for guidance on topic suitability and must adhere to compliance measures regarding foreign partnerships as outlined in the SBIR and STTR Extension Act of 2022.

    Files
    Title
    Posted
    FY25-SBIR-STTR-Phase-1-RFA-P.pdf
    The USDA is inviting applications for the 2025 Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs Phase I, with a total funding of $15.5 million available. The application deadline is September 17, 2024, and eligible applicants, particularly from underserved communities, are encouraged to engage in diverse research areas including climate-smart agriculture, food science, and rural development. The program aims to support the commercialization of innovative technologies while fostering partnerships between small businesses and research institutions.
    Similar Opportunities
    Small Business Innovation Research FY2025 Phase II
    DOC NOAA - ERA Production
    The National Oceanic and Atmospheric Administration (NOAA) is offering a funding opportunity through the Small Business Innovation Research (SBIR) program for small business concerns (SBCs) that received a Phase I award in FY 2024 to apply for Phase II funding in FY 2025. This grant aims to advance research and development efforts initiated in Phase I, with a focus on fostering technological innovation and enhancing participation from diverse groups in the research community, particularly in areas related to manufacturing innovation and energy efficiency. Eligible applicants can receive funding of up to $690,000 over a 24-month period, with applications accepted from January 10, 2025, to March 14, 2025. For further inquiries, interested parties can contact the SBIR Team at noaa.sbir@noaa.gov.
    Farm Business Management and Benchmarking Competitive Grants Program
    National Institute of Food and Agriculture
    The National Institute of Food and Agriculture (NIFA) is offering the Farm Business Management and Benchmarking Competitive Grants Program for fiscal year 2025, with an estimated total funding of $2 million. This program aims to enhance the management knowledge and skills of agricultural producers by maintaining and expanding a national financial management database, while also supporting educational initiatives across diverse agricultural communities. Eligible applicants include a wide range of entities such as state agricultural experiment stations, colleges, universities, private organizations, and individuals, with funding options available for Standard Grants up to $450,000 and Planning Grants up to $50,000. Applications are due by February 20, 2025, at 5:00 PM Eastern Time, and interested parties can direct inquiries to grantapplicationquestions@usda.gov for further assistance.
    PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), has announced the PHS 2024-2 Omnibus Solicitation for Small Business Innovation Research (SBIR) Grant Applications. This funding opportunity invites eligible U.S. small businesses to submit applications for Phase I, Phase II, Fast-Track, and Direct to Phase II projects that align with the research missions of the NIH, CDC, and FDA, with a focus on stimulating technological innovation and commercialization of federal R&D investments. Notably, applications must not include clinical trials, and funding levels are capped at $306,872 for Phase I and up to $2,045,816 for Phase II, with a submission deadline of April 5, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the PHS 2024-2 Omnibus Solicitation for Small Business Technology Transfer (STTR) Grant Applications, inviting eligible U.S. small businesses to submit proposals for innovative projects that align with NIH's research and development mission. This funding opportunity, identified as PA-24-247, specifically excludes clinical trials and aims to foster collaboration between small businesses and research institutions to advance technology development in health-related fields. Eligible applicants must be for-profit small businesses based in the U.S., with budget limits set at $306,872 for Phase I and $2,045,816 for Phase II awards. The application deadline is April 5, 2025, with an initial submission date of September 5, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the PHS 2024-2 Omnibus Solicitation for Small Business Technology Transfer (STTR) grant applications, inviting eligible U.S. small businesses to submit proposals that include at least one clinical trial. This funding opportunity aims to support research and development projects that align with the scientific missions of participating NIH Institutes and Centers, emphasizing the importance of innovation in health-related technologies. Eligible applicants must be U.S.-based small businesses with majority ownership by U.S. citizens or resident aliens, and the grants provide funding caps of up to $306,872 for Phase I and $2,045,816 for Phase II projects. Interested parties should note that the application deadline is April 5, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    FY 2025 Phase I Release 2
    Office of Science
    The Office of Science at the Department of Energy (DOE) has announced the FY 2025 Phase I Release 2 funding opportunity under the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. This initiative aims to support small, independent U.S. businesses in developing innovative technologies that align with DOE missions, with a total estimated funding of $65 million available for approximately 260 awards. Eligible applicants can receive grants ranging from $200,000 to $1.85 million, with application deadlines set for a Letter of Intent by January 14, 2025, and full applications by February 26, 2025. For further information, interested parties can contact Carl Hebron at (301) 903-5707 or via email at SBIR-STTR@science.doe.gov, and additional details can be found at https://science.osti.gov/sbir.
    PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) have announced the PHS 2024-2 Omnibus Solicitation for Small Business Innovation Research (SBIR) grant applications, specifically requiring clinical trials. This funding opportunity is aimed at U.S. small businesses with the necessary research capabilities to contribute to the missions of the NIH and CDC, encouraging innovation and the commercial viability of health technologies. Eligible applicants can receive funding up to $306,872 for Phase I and $2,045,816 for Phase II, with a submission deadline of April 5, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PA-24-246.html.
    FY2025 National Aquaculture Initiative: Strengthening U.S. Coastal, Marine, and Great Lakes Aquaculture Through Business Support
    DOC NOAA - ERA Production
    The Department of Commerce's National Oceanic and Atmospheric Administration (NOAA) is offering a federal grant opportunity titled "FY2025 National Aquaculture Initiative: Strengthening U.S. Coastal, Marine, and Great Lakes Aquaculture Through Business Support." This initiative aims to enhance U.S. aquaculture by providing funding for research projects that support the development of new aquaculture businesses and improve the efficiency and profitability of existing ones. With approximately $5 million available, applicants can request federal funding ranging from $100,000 to $1 million, with a proposal submission deadline of February 12, 2025. Interested parties should ensure they complete the necessary registrations with SAM.gov, Grants.gov, and eRA Commons, and may contact the National Sea Grant Office at oar.hq.sg.aquaculture@noaa.gov for further inquiries.
    Small Business Informatics Tools for the Pangenome (R41 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Business Informatics Tools for the Pangenome," aimed at supporting small business concerns (SBCs) in developing innovative informatics tools that enhance the use of the human pangenome reference. This initiative specifically seeks Phase I Small Business Technology Transfer (STTR) applications that demonstrate the technical merit and commercial viability of these tools, targeting various sectors within genomics, including clinical and functional genomics. The program is designed to foster small business participation in genomics technology development, ultimately improving health outcomes through advanced genomic capabilities and data analysis tools. Eligible applicants can request funding up to $400,000 over a one-year period, with key deadlines for letter of intent and application submissions set for early 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)" aimed at supporting Small Business Concerns (SBCs) in conducting investigator-initiated exploratory clinical trials related to neurological disorders. This initiative encourages applications for Phase I and II studies focusing on drugs, biologics, devices, and therapies that align with the mission of the National Institute of Neurological Disorders and Stroke (NINDS), emphasizing the inclusion of a Plan for Enhancing Diverse Perspectives (PEDP) to foster innovation. The maximum funding amounts are $295,924 for Phase I and $1,972,828 for Phase II projects, with applications required to demonstrate readiness for eventual FDA regulatory approval. Interested applicants can begin submitting proposals on December 5, 2023, with the application deadline set for September 5, 2026; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.